ArticleScientific reports2024

Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy.

Taiki Okumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.